METHOD FOR THE DETERMINATION OF PROCESSING INFLUENCES ON THE ENERGY VALUE OF FEEDSTUFF RAW MATERIALS AND/OR FEEDSTUFFS
申请人:Evonik Degussa GmbH
公开号:EP3567596A1
公开(公告)日:2019-11-13
The present invention relates to computer-implemented methods for the determination and/or assessment of processing influences on the energy value of a feedstuff raw material and/or feedstuff, in which the processing conditions indicator of the feedstuff raw material and/or feedstuff is determined and the corrected energy values of the feedstuff raw material and/or feedstuff is determined. The present invention also relates to a process for the preparation of a feed considering the determined processing influences and the energy values of feedstuff raw materials and/or feedstuffs.
METHOD FOR THE DETERMINATION OF PROCESSING INFLUENCES ON THE NUTRITIONAL VALUE OF FEEDSTUFF RAW MATERIALS
申请人:Evonik Operations GmbH
公开号:EP3361248B1
公开(公告)日:2019-12-18
PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS
申请人:Seattle Children's Hospital (dba Seattle Children's Research Institute)
公开号:US20200087399A1
公开(公告)日:2020-03-19
Aspects of the invention described herein relate to synthetic compounds that are useful for targeting and labeling tumor cells so as to facilitate recognition by binding agents including Chimeric Antigen Receptor T cells (CAR T cells), which are administered to a subject by intravenous or locoregional administration. Several compositions and methods of making and using these compositions to treat or inhibit a disease in a subject are contemplated.
METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS
申请人:Seattle Children's Hospital (dba Seattle Children's Research Institute)
公开号:US20210317407A1
公开(公告)日:2021-10-14
Some embodiments of the methods and compositions provided herein relate to the use of hapten labeled cells to stimulate chimeric antigen receptor (CAR) T cells. In some embodiments, CAR T cells can include a CAR that specifically binds to a hapten. Some embodiments relate to the in vivo or in vitro stimulation CAR T cells by hapten labeled cells.
TASTE-MASKED DOSAGE FORMS
申请人:MSB Holdings, Inc
公开号:US20210346385A1
公开(公告)日:2021-11-11
Sublingual dosage forms comprising a bitter active ingredient (including sildenafil, tadalafil, tetrahydrocannabinol, and cannabidiol) and a bitterness reducing agent are described. Methods of treating sexual dysfunction by administering the sublingual dosage form to an individual in need thereof are also described.